Extracted from this filing and checked against the source text.
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
BODY & MIND INC. completed an acquisition involving CraftedPlants NJ Corp. for 16,666,667 shares of common stock at a deemed price of CAD$0.08 per share and paid an aggregate of US$50,000 (closed 2022-12-21).
- Action
- acquisition
- Counterparty
- CraftedPlants NJ Corp.
- Consideration
- 16,666,667 shares of common stock at a deemed price of CAD$0.08 per share and paid an aggregate of US$50,000
- Closing
- 2022-12-21
Exact text from the filing
of CraftedPlants NJ Corp., which is now named, BaM Body and Mind Dispensary NJ, Inc. Pursuant to the closing of the Merger Agreement, the Company issued an aggregate of 16,666,667 shares of common stock to the Sellers at a deemed price of CAD$0.08 per share and paid an aggregate of US$50,000 to the Sellers, with a second delayed payment of US$120,000 to be
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
BODY & MIND INC. amended Limited Waiver and Amendment to Loan Agreement with FG Agency Lending, LLC and Bomind Holdings LLC valued at Waived specified defaults and amended financial reporting deadlines (effective 2022-12-12).
- Action
- amendment
- Agreement
- credit facility
- Counterparty
- FG Agency Lending, LLC and Bomind Holdings LLC
- Value
- Waived specified defaults and amended financial reporting deadlines
- Effective
- 2022-12-12
Exact text from the filing
On December 12, 2022, the Company, the Guarantors (collectively, the “ Loan Parties ”) the Agent and the Lender entered into a Limited Waiver and Amendment to Loan Agreement (the “ Limited Waiver and Amendment to Loan Agreement ”) to deal with certain events of default that occurred under the Loan Agreement, as amended, with respect to (i) the Company’s failure to deliver to Agent the audited annual financial statements of the Company and its subsidiaries for the fiscal year ended July 31, 2022, on or before ninety (90) days after the end of such fiscal year in accordance with Section 7.2(c) of the Loan Agreement (the “ First Specified Default ”) and (ii) the Agent being informed that the Company anticipates that it will fail to deliver the quarterly financial statements of the Company and its subsidiaries for the fiscal quarter ending October 31, 2022, in form and substance acceptable to Agent, on or before forty-five (45) days after the end of such fiscal quarter, in accordance with
View on SEC.gov